You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ELETRIPTAN HYDROBROMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Eletriptan Hydrobromide, and when can generic versions of Eletriptan Hydrobromide launch?

Eletriptan Hydrobromide is a drug marketed by Ajanta Pharma Ltd, Aurobindo Pharma, Beximco Pharms Usa, Mylan, Stevens J, Teva Pharms Usa, Yung Shin Pharm, and Zydus Pharms. and is included in eight NDAs.

The generic ingredient in ELETRIPTAN HYDROBROMIDE is eletriptan hydrobromide. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the eletriptan hydrobromide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Eletriptan Hydrobromide

A generic version of ELETRIPTAN HYDROBROMIDE was approved as eletriptan hydrobromide by ZYDUS PHARMS on June 16th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ELETRIPTAN HYDROBROMIDE?
  • What are the global sales for ELETRIPTAN HYDROBROMIDE?
  • What is Average Wholesale Price for ELETRIPTAN HYDROBROMIDE?
Drug patent expirations by year for ELETRIPTAN HYDROBROMIDE
Recent Clinical Trials for ELETRIPTAN HYDROBROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Phase 1

See all ELETRIPTAN HYDROBROMIDE clinical trials

Pharmacology for ELETRIPTAN HYDROBROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for ELETRIPTAN HYDROBROMIDE
Paragraph IV (Patent) Challenges for ELETRIPTAN HYDROBROMIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
RELPAX Tablets eletriptan hydrobromide 20 mg and 40 mg 021016 1 2010-03-29

US Patents and Regulatory Information for ELETRIPTAN HYDROBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ajanta Pharma Ltd ELETRIPTAN HYDROBROMIDE eletriptan hydrobromide TABLET;ORAL 205186-001 Aug 29, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan ELETRIPTAN HYDROBROMIDE eletriptan hydrobromide TABLET;ORAL 205152-001 Aug 11, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma ELETRIPTAN HYDROBROMIDE eletriptan hydrobromide TABLET;ORAL 210708-002 Jan 15, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa ELETRIPTAN HYDROBROMIDE eletriptan hydrobromide TABLET;ORAL 202040-002 Jun 27, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan ELETRIPTAN HYDROBROMIDE eletriptan hydrobromide TABLET;ORAL 205152-002 Aug 11, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms ELETRIPTAN HYDROBROMIDE eletriptan hydrobromide TABLET;ORAL 206409-002 Jun 16, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Yung Shin Pharm ELETRIPTAN HYDROBROMIDE eletriptan hydrobromide TABLET;ORAL 209680-002 Jul 13, 2020 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.